GRNA - Greenlight Biosciences Holdings PBC - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Greenlight Biosciences Holdings PBC's activity chart (see below) currently has 6 price targets and 4 ratings on display.

Stock Analyst Price Targets - Review

Most recent stock forecast was given by BOBBY BURLESON from on 31-May-2023. First documented stock forecast 14-Oct-2022.

John Roberts Bobby Burleson

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 31-May-2023

$3.7 (1233.33%)

3 years 3 months 29 days ago
(31-May-2023)

0/2 (0%)

$3.71 (1279.31%)

Hold Since 03-Apr-2023

$5.5

$5.2 (1733.33%)

$5.5

3 years 5 months 26 days ago
(03-Apr-2023)

0/2 (0%)

$5.02 (1045.83%)

Show more analysts

Which analyst most recently updated their price target on GRNA (Greenlight Biosciences Holdings PBC)?

Bobby Burleson

Which analyst has the current lower performing score on GRNA (Greenlight Biosciences Holdings PBC) with a proven track record?

BOBBY BURLESON

Which analyst has the most public recommendations on GRNA (Greenlight Biosciences Holdings PBC)?

Bobby Burleson has 3 price targets and 6 ratings on GRNA

Which analyst is the currently most bullish on GRNA (Greenlight Biosciences Holdings PBC)?

John Roberts with the highest potential upside of $5.2

Which analyst is the currently most reserved on GRNA (Greenlight Biosciences Holdings PBC)?

Bobby Burleson with the lowest potential downside of $3.7